IMHA Toolkit
Clinical protocols & thrombosis prevention awareness
Feline IMHA Dosage Calculator
Configured strictly to 2019 ACVIM Consensus Guidelines for Cats
1. Immunosuppressive Plan
๐ ACVIM Single vs. Dual Therapy Advisor
Check presenting clinical signs to evaluate if dual protocol is indicated immediately:
2. Mandatory Thromboprophylaxis
๐ Feline Diagnostic & Clinical Guidelines
๐ Spherocytes in Cats: Diagnostic Pitfalls
Unlike in dogs, true spherocytes are extremely difficult to identify in feline blood smears because normal feline red blood cells naturally lack prominent central pallor. Do not rely heavily on spherocytosis for diagnosing feline IMHA. Focus instead on auto-agglutination, Coombs' testing, and exclusion of secondary triggers.
๐งช Secondary Viral & Parasitic Screens
Most cases of feline IMHA are secondary to infectious agents or neoplasms. It is mandatory to run PCR/serology screens for **FeLV/FIV**, **Mycoplasma haemofelis** (Feline Infectious Anaemia), and *Cytauxzoon felis* before concluding that the disease is primary or autoimmune.
๐ฌ Mandatory Pre-Corticosteroid Feline Screening Guidelines โผ
Checking for Mycoplasma haemofelis (PCR): Feline infectious anaemia is caused by hemotropic mycoplasmas that physically attach to the surface of erythrocytes, triggering immune-mediated clearance. Initiating high-dose immunosuppressive corticosteroids without active parasitic coverage can lead to severe systemic replication of the parasite. Running a PCR assay is highly sensitive and mandatory for all presenting cats.
Screening for Feline Leukaemia Virus (FeLV): Underlying retroviral infections are strong secondary triggers for haematologic immune-mediated diseases in cats. Screening via ELISA or PCR for FeLV and FIV must be performed prior to starting chronic steroid regimens, as profound immunosuppression can accelerate viral disease expression and lead to fatal aplastic or neoplastic complications.
๐ Clinical Decision Guide: Single vs. Dual Protocols โผ
The Feline Corticosteroid Standard: Prednisolone is the first-line foundation of therapy. Cats cannot convert Prednisone to active Prednisolone efficiently in the liver, meaning Prednisone should *never* be prescribed. Mycophenolate Mofetil (MMF) serves as a secondary agent with a delayed clinical onset of several days.
When to use Dual Therapy (from Day 1): Initiate dual protocols concurrent with prednisolone immediately if the cat shows signs of severe haemolytic disease, active intravascular haemolysis, severe non-regenerative anaemia, or profound auto-agglutination.
When to use Sequential Therapy: If the patient presents with stable, regenerative extravascular IMHA, starting with Prednisolone alone is standard. Add Mycophenolate or secondary agents (such as Chlorambucil/Cyclosporine) later if treatment fails (PCV drops after 5-7 days of steroids) or severe steroid intolerances appear.